Elion Therapeutics Funding: $81M Raised, Series B (2024)
Elion Therapeutics is based in New York. It has raised $81M in total funding. Latest round: Series B.
Elion Therapeutics funding overview
Elion Therapeutics is based in New York. Elion Therapeutics has raised $81M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2024. The round record for Elion Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Deerfield Management, AMR Action Fund, Illinois Ventures, Boehringer Ingelheim Venture Fund, ARCH Venture Partners, Samsung Ventures and 1 others. 7 distinct backers are named across the disclosed rounds.
Elion Therapeutics at a glance
Total raised
$81M
Latest round
Series B
Latest round date
June 2024
Headquarters
New York
Notable investors
Deerfield Management, AMR Action Fund, Illinois Ventures, Boehringer Ingelheim Venture Fund, ARCH Venture Partners, Samsung Ventures, T1D Fund
Frequently asked about Elion Therapeutics funding
How much has Elion Therapeutics raised?
Elion Therapeutics has raised $81M in total disclosed funding across the rounds on record.
Who has invested in Elion Therapeutics?
Deerfield Management, AMR Action Fund, Illinois Ventures, Boehringer Ingelheim Venture Fund, ARCH Venture Partners, Samsung Ventures are named among the investors backing Elion Therapeutics.
What was the latest Elion Therapeutics funding round?
The most recent disclosed round is a Series B, announced in June 2024.
Where is Elion Therapeutics based?
Elion Therapeutics is based in New York.
When did Elion Therapeutics last raise?
The last disclosed Elion Therapeutics round closed in June 2024 at Series B.
Elion Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.
